Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray N Robertson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|June 14, 2011
Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazinesSaleh Ihmaid, Jasim Al-Rawi, Christopher Bradley, et al.
European Journal of Medicinal Chemistry|October 13, 2012
Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazinesSaleh K Ihmaid, Jasim M A Al-Rawi, Christopher J Bradley, et al.
Drug Discovery Today|June 16, 2010
The Drug Discovery Portal: a resource to enhance drug discovery from academiaRachel L Clark, Blair F Johnston, Simon P Mackay, et al.
Journal of Medicinal Chemistry|November 14, 2013
In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivativesMalay Patra, Katrin Ingram, Anna Leonidova, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoniIsabel Meister, Katrin Ingram-Sieber, Noemi Cowan, et al.
Current Pharmaceutical Design|March 13, 2010
The drug discovery portal: a computational platform for identifying drug leads from academiaRachel L Clark, Blair F Johnston, Simon P Mackay, et al.
Parasitology|August 30, 2013
Open source drug discovery - a limited tutorialMurray N Robertson, Paul M Ylioja, Alice E Williamson, et al.
The FEBS Journal|April 22, 2008
Characterization of Aquifex aeolicus 4-diphosphocytidyl-2C-methyl-d-erythritol kinase - ligand recognition in a template for antimicrobial drug discoveryTanja Sgraja, Magnus S Alphey, Stephanos Ghilagaber, et al.
Journal of Medicinal Chemistry|July 25, 2017
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related BiomarkersNahoum G Anthony, Jessica Baiget, Giacomo Berretta, et al.
Journal of Medicinal Chemistry|November 8, 2021
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel AntimalarialsEdwin G Tse, Laksh Aithani, Mark Anderson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|June 14, 2011
Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazinesSaleh Ihmaid, Jasim Al-Rawi, Christopher Bradley, et al.
European Journal of Medicinal Chemistry|October 13, 2012
Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazinesSaleh K Ihmaid, Jasim M A Al-Rawi, Christopher J Bradley, et al.
Drug Discovery Today|June 16, 2010
The Drug Discovery Portal: a resource to enhance drug discovery from academiaRachel L Clark, Blair F Johnston, Simon P Mackay, et al.
Journal of Medicinal Chemistry|November 14, 2013
In vitro metabolic profile and in vivo antischistosomal activity studies of (η(6)-praziquantel)Cr(CO)3 derivativesMalay Patra, Katrin Ingram, Anna Leonidova, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoniIsabel Meister, Katrin Ingram-Sieber, Noemi Cowan, et al.
Current Pharmaceutical Design|March 13, 2010
The drug discovery portal: a computational platform for identifying drug leads from academiaRachel L Clark, Blair F Johnston, Simon P Mackay, et al.
Parasitology|August 30, 2013
Open source drug discovery - a limited tutorialMurray N Robertson, Paul M Ylioja, Alice E Williamson, et al.
The FEBS Journal|April 22, 2008
Characterization of Aquifex aeolicus 4-diphosphocytidyl-2C-methyl-d-erythritol kinase - ligand recognition in a template for antimicrobial drug discoveryTanja Sgraja, Magnus S Alphey, Stephanos Ghilagaber, et al.
Journal of Medicinal Chemistry|July 25, 2017
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related BiomarkersNahoum G Anthony, Jessica Baiget, Giacomo Berretta, et al.
Journal of Medicinal Chemistry|November 8, 2021
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel AntimalarialsEdwin G Tse, Laksh Aithani, Mark Anderson, et al.
Pageof 2